Advertisement
Screener

BIOCLINICA INC Capital Expenditures

BIOCLINICA INC Capital Expenditures

BIOCLINICA INC reported Capital Expenditures of $3.92 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2013-02-22

  • BIOCLINICA INC payments to acquire property, plant, and equipment for the quarter ending 2012-12-31 was $613.00K, a 20.91% increase year-over-year.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for the quarter ending 2012-09-30 was $2.35M, a 282.08% increase year-over-year.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $700.00K, a 60.92% increase year-over-year.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $259.00K, a 14.52% decline year-over-year.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for fiscal 2012 was $3.92M, a 110.76% increase from fiscal 2011.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for fiscal 2011 was $1.86M, a 36.25% decline from fiscal 2010.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for fiscal 2010 was $2.92M, a 5.54% increase from fiscal 2009.
  • BIOCLINICA INC payments to acquire property, plant, and equipment for fiscal 2009 was $2.76M.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2012-12-31$613.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$2.96M
derived: sum of 2 quarters · filed 2013-02-22
$3.66M
derived: sum of 3 quarters · filed 2013-02-22
$3.92M
10-K · filed 2013-02-22
2012-09-30$2.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$3.05M
derived: sum of 2 quarters · filed 2012-11-09
$3.31M
10-Q · filed 2012-11-09
$3.81M
derived: sum of 4 quarters · filed 2013-02-22
2012-06-30$700.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$959.00K
10-Q · filed 2012-08-09
$1.47M
derived: sum of 3 quarters · filed 2013-02-22
$2.08M
derived: sum of 4 quarters · filed 2013-02-22
2012-03-31$259.00K
10-Q · filed 2012-05-10
$766.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.38M
derived: sum of 3 quarters · filed 2013-02-22
$1.81M
derived: sum of 4 quarters · filed 2013-02-22
2011-12-31$507.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.12M
derived: sum of 2 quarters · filed 2013-02-22
$1.56M
derived: sum of 3 quarters · filed 2013-02-22
$1.86M
10-K · filed 2013-02-22
2011-09-30$614.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$1.05M
derived: sum of 2 quarters · filed 2012-11-09
$1.35M
10-Q · filed 2012-11-09
$1.97M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$435.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$738.00K
10-Q · filed 2012-08-09
$351.00K
10-Q · filed 2011-08-08
$1.36M
derived: sum of 3 quarters · filed 2013-02-22
$1.65M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$303.00K
10-Q · filed 2012-05-10
$923.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.22M
derived: sum of 3 quarters · filed 2013-02-22
2010-12-31$620.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$915.00K
derived: sum of 2 quarters · filed 2013-02-22
$2.92M
10-K · filed 2013-02-22
2010-09-30$295.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$2.30M
10-Q · filed 2011-11-14
2010-06-30$2.00M
10-Q · filed 2011-08-08
2009-12-31$2.76M
10-K · filed 2012-02-27